BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25764315)

  • 1. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
    Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
    Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
    Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
    Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
    Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
    Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.
    Garcia CM; Maleki A; Look-Why S; Manhapra A; Durrani K; Foster CS
    Retin Cases Brief Rep; 2023 Jul; 17(4):384-388. PubMed ID: 34618714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
    Dot C; Guigay J; Adamus G
    Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
    Oporto Caroca JI; Oporto Caroca J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological characterization of paraneoplastic retinopathy.
    Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 11. Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.
    Fox AR; Gordon LK; Heckenlively JR; Davis JL; Goldstein DA; Lowder CY; Nussenblatt RB; Butler NJ; Dalal M; Jayasundera T; Smith WM; Lee RW; Adamus G; Chan CC; Hooks JJ; Morgans CW; Detrick B; Sen HN
    Am J Ophthalmol; 2016 Aug; 168():183-190. PubMed ID: 27210277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretinal antibody- proven autoimmune retinopathy.
    Abraham S; Sudharshan S; Bhende M; Ganesh SK; Gopal S
    Indian J Ophthalmol; 2017 May; 65(5):416-420. PubMed ID: 28574003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune retinopathy.
    Grange L; Dalal M; Nussenblatt RB; Sen HN
    Am J Ophthalmol; 2014 Feb; 157(2):266-272.e1. PubMed ID: 24315290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presumed autoimmune retinopathy following chickenpox; a case report.
    Prime Z; Sims J; Danesh-Meyer H
    Int Ophthalmol; 2018 Oct; 38(5):2187-2190. PubMed ID: 28825165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune retinopathies: a report of 3 cases.
    Oray M; Kir N; Tuncer S; Onal S; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2013 Dec; 21(6):424-33. PubMed ID: 23730997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
    Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
    BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of autoimmune retinopathies with immunosuppression.
    Ferreyra HA; Jayasundera T; Khan NW; He S; Lu Y; Heckenlively JR
    Arch Ophthalmol; 2009 Apr; 127(4):390-7. PubMed ID: 19365013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy.
    Faez S; Loewenstein J; Sobrin L
    JAMA Ophthalmol; 2013 Jan; 131(1):113-5. PubMed ID: 23307224
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy.
    Pawestri AR; Arjkongharn N; Suvannaboon R; Tuekprakhon A; Srimuninnimit V; Udompunthurak S; Atchaneeyasakul LO; Koolvisoot A; Trinavarat A
    Sci Rep; 2021 Jul; 11(1):15047. PubMed ID: 34294798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.